Deep-tissue localization of magnetic field hyperthermia using pulse sequencing
Objective Deep-tissue localization of thermal doses is a long-standing challenge in magnetic field hyperthermia (MFH), and remains a limitation of the clinical application of MFH to date. Here, we show that pulse sequencing of MFH leads to a more persistent inhibition of tumor growth and less system...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | International Journal of Hyperthermia |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/02656736.2021.1912412 |
id |
doaj-360575b57d59400c930b4c1f5a733fdf |
---|---|
record_format |
Article |
spelling |
doaj-360575b57d59400c930b4c1f5a733fdf2021-07-06T11:30:09ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572021-01-0138174375410.1080/02656736.2021.19124121912412Deep-tissue localization of magnetic field hyperthermia using pulse sequencingFelista L. Tansi0Wisdom O. Maduabuchi1Melanie Hirsch2Paul Southern3Simon Hattersley4Rainer Quaas5Ulf Teichgräber6Quentin A. Pankhurst7Ingrid Hilger8Institute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital – Friedrich Schiller University JenaInstitute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital – Friedrich Schiller University JenaInstitute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital – Friedrich Schiller University JenaResonant Circuits LimitedResonant Circuits LimitedChemicell GmbHInstitute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital – Friedrich Schiller University JenaResonant Circuits LimitedInstitute of Diagnostic and Interventional Radiology, Department of Experimental Radiology, Jena University Hospital – Friedrich Schiller University JenaObjective Deep-tissue localization of thermal doses is a long-standing challenge in magnetic field hyperthermia (MFH), and remains a limitation of the clinical application of MFH to date. Here, we show that pulse sequencing of MFH leads to a more persistent inhibition of tumor growth and less systemic impact than continuous MFH, even when delivering the same thermal dose. Methods We used an in vivo orthotopic murine model of pancreatic PANC-1 cancer, which was designed with a view to the forthcoming ‘NoCanTher’ clinical study, and featured MFH alongside systemic chemotherapy (SyC: gemcitabine and nab-paclitaxel). In parallel, in silico thermal modelling was implemented. Results Tumor volumes 27 days after the start of MFH/SyC treatment were 53% (of the initial volume) in the pulse MFH group, compared to 136% in the continuous MFH group, and 337% in the non-treated controls. Systemically, pulse MFH led to ca. 50% less core-temperature increase in the mice for a given injected dose of magnetic heating agent, and inflicted lower levels of the stress marker, as seen in the blood-borne neutrophil-to-lymphocyte ratio (1.7, compared to 3.2 for continuous MFH + SyC, and 1.2 for controls). Conclusion Our data provided insights into the influence of pulse sequencing on the observed biological outcomes, and validated the nature of the improved thermal dose localization, alongside significant lowering of the overall energy expenditure entailed in the treatment.http://dx.doi.org/10.1080/02656736.2021.1912412pulse magnetic hyperthermiatemperature oscillationsintermittent hyperthermiapulsatile heatingthermoablation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Felista L. Tansi Wisdom O. Maduabuchi Melanie Hirsch Paul Southern Simon Hattersley Rainer Quaas Ulf Teichgräber Quentin A. Pankhurst Ingrid Hilger |
spellingShingle |
Felista L. Tansi Wisdom O. Maduabuchi Melanie Hirsch Paul Southern Simon Hattersley Rainer Quaas Ulf Teichgräber Quentin A. Pankhurst Ingrid Hilger Deep-tissue localization of magnetic field hyperthermia using pulse sequencing International Journal of Hyperthermia pulse magnetic hyperthermia temperature oscillations intermittent hyperthermia pulsatile heating thermoablation |
author_facet |
Felista L. Tansi Wisdom O. Maduabuchi Melanie Hirsch Paul Southern Simon Hattersley Rainer Quaas Ulf Teichgräber Quentin A. Pankhurst Ingrid Hilger |
author_sort |
Felista L. Tansi |
title |
Deep-tissue localization of magnetic field hyperthermia using pulse sequencing |
title_short |
Deep-tissue localization of magnetic field hyperthermia using pulse sequencing |
title_full |
Deep-tissue localization of magnetic field hyperthermia using pulse sequencing |
title_fullStr |
Deep-tissue localization of magnetic field hyperthermia using pulse sequencing |
title_full_unstemmed |
Deep-tissue localization of magnetic field hyperthermia using pulse sequencing |
title_sort |
deep-tissue localization of magnetic field hyperthermia using pulse sequencing |
publisher |
Taylor & Francis Group |
series |
International Journal of Hyperthermia |
issn |
0265-6736 1464-5157 |
publishDate |
2021-01-01 |
description |
Objective Deep-tissue localization of thermal doses is a long-standing challenge in magnetic field hyperthermia (MFH), and remains a limitation of the clinical application of MFH to date. Here, we show that pulse sequencing of MFH leads to a more persistent inhibition of tumor growth and less systemic impact than continuous MFH, even when delivering the same thermal dose. Methods We used an in vivo orthotopic murine model of pancreatic PANC-1 cancer, which was designed with a view to the forthcoming ‘NoCanTher’ clinical study, and featured MFH alongside systemic chemotherapy (SyC: gemcitabine and nab-paclitaxel). In parallel, in silico thermal modelling was implemented. Results Tumor volumes 27 days after the start of MFH/SyC treatment were 53% (of the initial volume) in the pulse MFH group, compared to 136% in the continuous MFH group, and 337% in the non-treated controls. Systemically, pulse MFH led to ca. 50% less core-temperature increase in the mice for a given injected dose of magnetic heating agent, and inflicted lower levels of the stress marker, as seen in the blood-borne neutrophil-to-lymphocyte ratio (1.7, compared to 3.2 for continuous MFH + SyC, and 1.2 for controls). Conclusion Our data provided insights into the influence of pulse sequencing on the observed biological outcomes, and validated the nature of the improved thermal dose localization, alongside significant lowering of the overall energy expenditure entailed in the treatment. |
topic |
pulse magnetic hyperthermia temperature oscillations intermittent hyperthermia pulsatile heating thermoablation |
url |
http://dx.doi.org/10.1080/02656736.2021.1912412 |
work_keys_str_mv |
AT felistaltansi deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT wisdomomaduabuchi deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT melaniehirsch deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT paulsouthern deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT simonhattersley deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT rainerquaas deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT ulfteichgraber deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT quentinapankhurst deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing AT ingridhilger deeptissuelocalizationofmagneticfieldhyperthermiausingpulsesequencing |
_version_ |
1721317625252806656 |